Impact of decreasing copayments on medication adherence within a disease management environment

被引：240

作者：

Chernew, Michael E. ^{[1
]}

Shah, Mayur R. ^{[2
]}

Wegh, Arnold ^{[3
]}

Rosenberg, Stephen N.

Juster, Iver A.

Rosen, Allison B. ^{[4
,5
]}

Sokol, Michael C. ^{[6
]}

Yu-Isenberg, Kristina ^{[7
]}

Fendrick, A. Mark ^{[8
]}

机构：

[1] Harvard Univ, Sch Med, Boston, MA 02115 USA

[2] ActiveHlth Management, New York, NY USA

[3] SAS Programmer Informat, Atlanta, GA USA

[4] Univ Michigan, Ann Arbor, MI 48109 USA

[5] Ann Arbor Vet Affairs Med Ctr, Ann Arbor, MI 48105 USA

[6] GlaxoSmithKline Inc, HMI, Montvale, NJ USA

[7] GlaxoSmithKline Inc, HMi, Res Triangle Pk, NC USA

[8] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI 48109 USA

来源：

HEALTH AFFAIRS | 2008年 / 27卷 / 01期

关键词：

D O I：

10.1377/hlthaff.27.1.103

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

This paper estimates the effects of a large employer's value-based insurance initiative designed to improve adherence to recommended treatment regimens. The intervention reduced copayments for five chronic medication classes in the context of a disease management (DM) program. Compared to a control employer that used the same DM program, adherence to medications in the value-based intervention increased for four of five medication classes, reducing nonadherence by 7-14 percent. The results demonstrate the potential for copayment reductions for highly valued services to increase medication adherence above the effects of existing DM programs.

引用

页码：103 / 112

页数：10

共 17 条

[1] Methods for evaluation of medication adherence and persistence using automated databases [J].